Report: Invitrogen, Sigma Largest Suppliers of Cell Culture Research Media
According to a market research report released this week from Percepta Associates, Invitrogen and Sigma-Aldrich split about half the market for cell culture research media.
In the study, “Cell Culture Dashboard,” around 23.2 percent of 365 scientists surveyed listed Invitrogen and 22.7 percent listed Sigma as their “primary supplier” of the cell culture market, which includes basal media, animal sera, balanced salt solutions, serum free media, dry powdered media, and growth and attachment factors.
Invitrogen leads the market for animal sera, while Sigma is the leading supplier of growth and attachment factors to the academic market, the Percepta said. Invitrogen has a larger share of the European market, while Sigma’s share is slightly greater in North America.
Percepta said that more than 20 percent of respondents in four of the six market segments surveyed reported that they are considering switching to a different supplier.
MDS Sciex Reports 4-Percent Rise in Organic Q4 Revenue
MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
Revenue drivers included the small molecule and applied markets and in Europe, MDS said.
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
R&D spending remained flat at $4 million.
The company did not break out earnings or a balance sheet for the unit.
Last month, announced plans to plans to acquire Molecular Devices for $615 million in cash and integrate it with the MDS Sciex unit [CBA News 02-02-07].